526 related articles for article (PubMed ID: 1422579)
1. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
2. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
[TBL] [Abstract][Full Text] [Related]
3. Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents.
Berry JL; Small RC; Foster RW
Br J Pharmacol; 1992 Aug; 106(4):813-8. PubMed ID: 1393280
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
Kwan YW; To KW; Lau WM; Tsang SH
Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
[TBL] [Abstract][Full Text] [Related]
5. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes.
Escande D; Thuringer D; Le Guern S; Courteix J; Laville M; Cavero I
Pflugers Arch; 1989 Sep; 414(6):669-75. PubMed ID: 2510125
[TBL] [Abstract][Full Text] [Related]
6. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.
Cook NS; Quast U; Hof RP; Baumlin Y; Pally C
J Cardiovasc Pharmacol; 1988 Jan; 11(1):90-9. PubMed ID: 2450263
[TBL] [Abstract][Full Text] [Related]
7. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.
Meisheri KD; Khan SA; Martin JL
J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.
Edwards G; Henshaw M; Miller M; Weston AH
Br J Pharmacol; 1991 Mar; 102(3):679-86. PubMed ID: 1364839
[TBL] [Abstract][Full Text] [Related]
9. Relaxant effects of the potassium channel activators BRL 38227 and pinacidil on guinea-pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660.
Buckle DR; Arch JR; Bowring NE; Foster KA; Taylor JF; Taylor SG; Shaw DJ
Pulm Pharmacol; 1993 Mar; 6(1):77-86. PubMed ID: 8477155
[TBL] [Abstract][Full Text] [Related]
10. Increased vasodilator responsiveness to BRL 34915 in spontaneously hypertensive versus normotensive rats: contrast with nifedipine.
Falotico R; Keiser J; Haertlein B; Cheung WM; Tobia A
Proc Soc Exp Biol Med; 1989 Feb; 190(2):179-85. PubMed ID: 2915996
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
[TBL] [Abstract][Full Text] [Related]
12. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
Cavero I; Mondot S; Mestre M
J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
[TBL] [Abstract][Full Text] [Related]
13. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
McPherson GA; Stork AP
Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
[TBL] [Abstract][Full Text] [Related]
14. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
McPherson GA; Angus JA
Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the effects of potassium channel modulating agents on mouse intestinal smooth muscle.
Yeung CK; McCurrie JR; Wood D
J Pharm Pharmacol; 2002 Mar; 54(3):425-33. PubMed ID: 11902810
[TBL] [Abstract][Full Text] [Related]
16. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
Greenwood IA; Weston AH
Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
[TBL] [Abstract][Full Text] [Related]
17. Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed.
McCulloch AI; Randall MD
Br J Pharmacol; 1996 Mar; 117(5):859-66. PubMed ID: 8851502
[TBL] [Abstract][Full Text] [Related]
18. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
Quast U; Villhauer EB
Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
[TBL] [Abstract][Full Text] [Related]
19. KATP channel openers reverse immune complex-induced airways hyperreactivity independently of smooth muscle relaxation.
Buchheit KH; Hofmann A
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):355-61. PubMed ID: 8878067
[TBL] [Abstract][Full Text] [Related]
20. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
